Literature DB >> 32042627

Holding a MIRror up to the robustness of the prostate cancer urinary transcriptome.

Adele E Connor1,2, Asia C Jordan1,2, Antoinette S Perry1,2.   

Abstract

Entities:  

Year:  2019        PMID: 32042627      PMCID: PMC6989850          DOI: 10.21037/tau.2019.09.25

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
  15 in total

1.  Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.

Authors:  Jacob Fredsøe; Anne K I Rasmussen; Anni R Thomsen; Peter Mouritzen; Søren Høyer; Michael Borre; Torben F Ørntoft; Karina D Sørensen
Journal:  Eur Urol Focus       Date:  2017-03-09

2.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

3.  The microRNA spectrum in 12 body fluids.

Authors:  Jessica A Weber; David H Baxter; Shile Zhang; David Y Huang; Kuo How Huang; Ming Jen Lee; David J Galas; Kai Wang
Journal:  Clin Chem       Date:  2010-09-16       Impact factor: 8.327

Review 4.  The translational potential of microRNAs as biofluid markers of urological tumours.

Authors:  Annika Fendler; Carsten Stephan; George M Yousef; Glen Kristiansen; Klaus Jung
Journal:  Nat Rev Urol       Date:  2016-11-02       Impact factor: 14.432

Review 5.  ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

Authors:  Scott A Tomlins; Anders Bjartell; Arul M Chinnaiyan; Guido Jenster; Robert K Nam; Mark A Rubin; Jack A Schalken
Journal:  Eur Urol       Date:  2009-04-24       Impact factor: 20.096

6.  DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Authors:  Daphne Hessels; Jacqueline M T Klein Gunnewiek; Inge van Oort; Herbert F M Karthaus; Geert J L van Leenders; Bianca van Balken; Lambertus A Kiemeney; J Alfred Witjes; Jack A Schalken
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

7.  A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.

Authors:  James McKiernan; Michael J Donovan; Vince O'Neill; Stefan Bentink; Mikkel Noerholm; Susan Belzer; Johan Skog; Michael W Kattan; Alan Partin; Gerald Andriole; Gordon Brown; John T Wei; Ian M Thompson; Peter Carroll
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

8.  Changes in circulating microRNA levels associated with prostate cancer.

Authors:  R J Bryant; T Pawlowski; J W F Catto; G Marsden; R L Vessella; B Rhees; C Kuslich; T Visakorpi; F C Hamdy
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

9.  Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.

Authors:  Marta Rodríguez; Cristina Bajo-Santos; Nina P Hessvik; Susanne Lorenz; Bastian Fromm; Viktor Berge; Kirsten Sandvig; Aija Linē; Alicia Llorente
Journal:  Mol Cancer       Date:  2017-10-05       Impact factor: 27.401

10.  A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients.

Authors:  Shea P Connell; Marcel Hanna; Frank McCarthy; Rachel Hurst; Martyn Webb; Helen Curley; Helen Walker; Rob Mills; Richard Y Ball; Martin G Sanda; Kathryn L Pellegrini; Dattatraya Patil; Antoinette S Perry; Jack Schalken; Hardev Pandha; Hayley Whitaker; Nening Dennis; Christine Stuttle; Ian G Mills; Ingrid Guldvik; Chris Parker; Daniel S Brewer; Colin S Cooper; Jeremy Clark
Journal:  BJU Int       Date:  2019-05-20       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.